Expression of drug resistance-associated mdr-1, GST π, and topoisomerase II genes during cell cycle traverse

Cheppail Ramachandran, Dana Mead, Larry L. Wellham, Antonieta Sauerteig, Awtar Krishan

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The expression of drug resistance-associated mdr-1, GST π, and topoisomerase II genes was analyzed in cell cycle phase enriched populations of doxorubicin-resistant murine leukemic P388/R-84 cells. Flow cytometric analysis of bromodeoxyuridine (BrdU) incorporation and staining with anti-BrdU antibodies was used to confirm the purity of cell cycle phase enriched populations obtained by centrifugal elutriation. Doxorubicin (DOX) and daunorubicin (DNR) accumulation was significantly lower in S-phase cells, and coincubation with verapamil (VPL) or chlorpromazine (CPZ) enhanced DOX and DNR accumulation more in S-phase than in G1- and G2 M-phase cells. While the cellular content of mdr-1 and topoisomerase II mRNAs changed, GST π mRNA content remained constant during the cell cycle. S-phase cells had about 3-fold higher mdr-1 mRNA content than G1- and G2 M-phase cells. In G1 cells, P-glycoprotein expression, as determined by C219 monoclonal antibody, was 12% less than that of S and G2 M cells. Topoisomerase II mRNA content increased with the progression of cell cycle and peaked in G2 M cells. These observations suggest that cell cycle stage related changes in expression of drug resistance markers may have a major bearing on chemosensitivity of drug-resistant cells.

Original languageEnglish
Pages (from-to)545-552
Number of pages8
JournalBiochemical Pharmacology
Volume49
Issue number4
DOIs
StatePublished - Feb 14 1995
Externally publishedYes

Fingerprint

cdc Genes
Type II DNA Topoisomerase
Drug Resistance
Genes
Cells
Doxorubicin
Messenger RNA
Daunorubicin
Pharmaceutical Preparations
Cell Cycle
Bromodeoxyuridine
S Phase
G2 Phase
Chlorpromazine
P-Glycoprotein
Cell Division
Verapamil
Monoclonal Antibodies
leukotriene-C4 synthase
Antibodies

Keywords

  • cell cycle
  • doxorubicin
  • glutathione S-transferase
  • multidrug resistance
  • P-glycoprotein
  • topoisomerase II

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Expression of drug resistance-associated mdr-1, GST π, and topoisomerase II genes during cell cycle traverse. / Ramachandran, Cheppail; Mead, Dana; Wellham, Larry L.; Sauerteig, Antonieta; Krishan, Awtar.

In: Biochemical Pharmacology, Vol. 49, No. 4, 14.02.1995, p. 545-552.

Research output: Contribution to journalArticle

Ramachandran, Cheppail ; Mead, Dana ; Wellham, Larry L. ; Sauerteig, Antonieta ; Krishan, Awtar. / Expression of drug resistance-associated mdr-1, GST π, and topoisomerase II genes during cell cycle traverse. In: Biochemical Pharmacology. 1995 ; Vol. 49, No. 4. pp. 545-552.
@article{29e3e524bd464b6c86b2e75a51e0be68,
title = "Expression of drug resistance-associated mdr-1, GST π, and topoisomerase II genes during cell cycle traverse",
abstract = "The expression of drug resistance-associated mdr-1, GST π, and topoisomerase II genes was analyzed in cell cycle phase enriched populations of doxorubicin-resistant murine leukemic P388/R-84 cells. Flow cytometric analysis of bromodeoxyuridine (BrdU) incorporation and staining with anti-BrdU antibodies was used to confirm the purity of cell cycle phase enriched populations obtained by centrifugal elutriation. Doxorubicin (DOX) and daunorubicin (DNR) accumulation was significantly lower in S-phase cells, and coincubation with verapamil (VPL) or chlorpromazine (CPZ) enhanced DOX and DNR accumulation more in S-phase than in G1- and G2 M-phase cells. While the cellular content of mdr-1 and topoisomerase II mRNAs changed, GST π mRNA content remained constant during the cell cycle. S-phase cells had about 3-fold higher mdr-1 mRNA content than G1- and G2 M-phase cells. In G1 cells, P-glycoprotein expression, as determined by C219 monoclonal antibody, was 12{\%} less than that of S and G2 M cells. Topoisomerase II mRNA content increased with the progression of cell cycle and peaked in G2 M cells. These observations suggest that cell cycle stage related changes in expression of drug resistance markers may have a major bearing on chemosensitivity of drug-resistant cells.",
keywords = "cell cycle, doxorubicin, glutathione S-transferase, multidrug resistance, P-glycoprotein, topoisomerase II",
author = "Cheppail Ramachandran and Dana Mead and Wellham, {Larry L.} and Antonieta Sauerteig and Awtar Krishan",
year = "1995",
month = "2",
day = "14",
doi = "10.1016/0006-2952(94)00443-P",
language = "English",
volume = "49",
pages = "545--552",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Expression of drug resistance-associated mdr-1, GST π, and topoisomerase II genes during cell cycle traverse

AU - Ramachandran, Cheppail

AU - Mead, Dana

AU - Wellham, Larry L.

AU - Sauerteig, Antonieta

AU - Krishan, Awtar

PY - 1995/2/14

Y1 - 1995/2/14

N2 - The expression of drug resistance-associated mdr-1, GST π, and topoisomerase II genes was analyzed in cell cycle phase enriched populations of doxorubicin-resistant murine leukemic P388/R-84 cells. Flow cytometric analysis of bromodeoxyuridine (BrdU) incorporation and staining with anti-BrdU antibodies was used to confirm the purity of cell cycle phase enriched populations obtained by centrifugal elutriation. Doxorubicin (DOX) and daunorubicin (DNR) accumulation was significantly lower in S-phase cells, and coincubation with verapamil (VPL) or chlorpromazine (CPZ) enhanced DOX and DNR accumulation more in S-phase than in G1- and G2 M-phase cells. While the cellular content of mdr-1 and topoisomerase II mRNAs changed, GST π mRNA content remained constant during the cell cycle. S-phase cells had about 3-fold higher mdr-1 mRNA content than G1- and G2 M-phase cells. In G1 cells, P-glycoprotein expression, as determined by C219 monoclonal antibody, was 12% less than that of S and G2 M cells. Topoisomerase II mRNA content increased with the progression of cell cycle and peaked in G2 M cells. These observations suggest that cell cycle stage related changes in expression of drug resistance markers may have a major bearing on chemosensitivity of drug-resistant cells.

AB - The expression of drug resistance-associated mdr-1, GST π, and topoisomerase II genes was analyzed in cell cycle phase enriched populations of doxorubicin-resistant murine leukemic P388/R-84 cells. Flow cytometric analysis of bromodeoxyuridine (BrdU) incorporation and staining with anti-BrdU antibodies was used to confirm the purity of cell cycle phase enriched populations obtained by centrifugal elutriation. Doxorubicin (DOX) and daunorubicin (DNR) accumulation was significantly lower in S-phase cells, and coincubation with verapamil (VPL) or chlorpromazine (CPZ) enhanced DOX and DNR accumulation more in S-phase than in G1- and G2 M-phase cells. While the cellular content of mdr-1 and topoisomerase II mRNAs changed, GST π mRNA content remained constant during the cell cycle. S-phase cells had about 3-fold higher mdr-1 mRNA content than G1- and G2 M-phase cells. In G1 cells, P-glycoprotein expression, as determined by C219 monoclonal antibody, was 12% less than that of S and G2 M cells. Topoisomerase II mRNA content increased with the progression of cell cycle and peaked in G2 M cells. These observations suggest that cell cycle stage related changes in expression of drug resistance markers may have a major bearing on chemosensitivity of drug-resistant cells.

KW - cell cycle

KW - doxorubicin

KW - glutathione S-transferase

KW - multidrug resistance

KW - P-glycoprotein

KW - topoisomerase II

UR - http://www.scopus.com/inward/record.url?scp=0028890696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028890696&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(94)00443-P

DO - 10.1016/0006-2952(94)00443-P

M3 - Article

C2 - 7872960

AN - SCOPUS:0028890696

VL - 49

SP - 545

EP - 552

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 4

ER -